Table 3.

GMM Analysis Results of the Application Example

Estimation Procedu Reference Group	3-step Hybrid RSG	3-Step Hybrid SU+MET	3-Step –
Poor Control Stratum (22%)	Estimate & 95% CI
Baseline HbA1c	8.55 (8.42,8.68)	8.41 (8.33,8.49)	8.45 (8.30,8.60)
Post-treatment HbA1c	8.60 (8.41,8.78)	8.38 (8.25,8.50)	8.49 (8.27,8.71)
RSG Effect on HbA1c	0.36 (0.00,0.72)	0.23 (−0.08,0.54)	−0.07 (−0.36,0.22)
RSG Effect on CVD (Odds Ratio)	0.28 (0.09,0.83)	0.35 (0.15,0.83)	0.37 (0.16,0.85)
RSG Effect on Death (Odds Ratio)	0.66 (0.28,1.51)	0.70 (0.36,1.37)	0.84 (0.44,1.61)
Better Control Stratum (78%)	Estimate & 95% CI
Baseline HbA1c	7.23 (7.20,7.25)	7.17 (7.14,7.19)	7.18 (7.14,7.22)
Post-treatment HbA1c	7.00 (6.96,7.03)	6.95 (6.92,6.98)	6.96 (6.92,7.01)
RSG Effect on HbA1c	0.09 (0.01,0.16)	0.09 (0.01,0.17)	0.07 (−0.01,0.15)
RSG Effect on CVD (Odds Ratio)	0.76 (0.55,1.06)	0.77 (0.55,1.08)	0.77 (0.55,1.07)
RSG Effect on Death (Odds Ratio)	1.18 (0.88,1.57)	1.19 (0.88,1.60)	1.15 (0.86,1.56)